<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Computational Analysis of Disease Progression in Pediatric Pulmonary Arterial Hypertension - Health AI Hub</title>
    <meta name="description" content="This study developed and calibrated multi-scale, patient-specific cardiovascular models for pediatric Pulmonary Arterial Hypertension (PAH) using longitudinal M">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Computational Analysis of Disease Progression in Pediatric Pulmonary Arterial Hypertension</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.25027v1" target="_blank">2512.25027v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-31
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Omar Said, Christopher Tossas-Betancourt, Mary K. Olive, Jimmy C. Lu, Adam Dorfman, C. Alberto Figueroa
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.med-ph, physics.comp-ph, physics.flu-dyn
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.25027v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.25027v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This study developed and calibrated multi-scale, patient-specific cardiovascular models for pediatric Pulmonary Arterial Hypertension (PAH) using longitudinal MRI and catheterization data. The computational models successfully captured patient-specific hemodynamic adaptation over time, with derived metrics aligning with clinical indicators of disease severity and progression, demonstrating a promising non-invasive monitoring tool.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research addresses the critical need for better diagnostic and monitoring tools in pediatric PAH, a severe and understudied disease. By offering a non-invasive method to assess hemodynamic changes and disease progression, it can reduce reliance on invasive procedures and provide valuable insights for personalized treatment strategies.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The paper describes the development of an 'automated Python-based optimizer' to calibrate complex multi-scale, patient-specific cardiovascular models using longitudinal MRI and catheterization data. This application of an automated optimization algorithm to clinical data for patient-specific modeling, disease monitoring, and informing treatment strategies falls under medical AI. It represents the use of computational intelligence to enhance diagnostic and prognostic capabilities, moving towards personalized digital patient models for healthcare.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Pediatric Pulmonary Arterial Hypertension (PAH) is a progressive, understudied cardiopulmonary disease.</li>
                    
                    <li>Developed multi-scale, patient-specific cardiovascular models for four pediatric PAH patients using longitudinal MRI and catheterization data collected approximately two years apart.</li>
                    
                    <li>Utilized the CRIMSON simulation framework, coupling 3D Fluid-Structure Interaction (FSI) models of pulmonary arteries with 0D lumped-parameter heart and Windkessel models.</li>
                    
                    <li>An automated Python-based optimizer was developed for boundary condition calibration, reducing calibration time from weeks to days.</li>
                    
                    <li>Model-derived metrics, including arterial stiffness, pulse wave velocity, resistance, and compliance, showed alignment with clinical indicators of disease severity and progression.</li>
                    
                    <li>The computational modeling approach demonstrated the ability to non-invasively capture patient-specific hemodynamic adaptation over time.</li>
                    
                    <li>The study proposes computational modeling as a promising tool for monitoring pediatric PAH and informing future treatment strategies.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study involved developing and calibrating multi-scale, patient-specific cardiovascular models. This was achieved by coupling 3D Fluid-Structure Interaction (FSI) models of the pulmonary arteries with 0D lumped-parameter heart and Windkessel models within the CRIMSON simulation framework. Model calibration utilized longitudinal MRI and catheterization data collected from four pediatric PAH patients. An automated Python-based optimizer was developed to efficiently calibrate boundary conditions by minimizing discrepancies between simulated and clinical metrics.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The key findings include the successful development and calibration of computational models that accurately reflect patient-specific hemodynamics. Model-derived metrics such as arterial stiffness, pulse wave velocity (PWV), resistance, and compliance were found to align significantly with established clinical indicators of PAH disease severity and progression. The models demonstrated the capability to non-invasively capture hemodynamic adaptation in patients over a two-year period.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research offers a potential paradigm shift in monitoring pediatric PAH by providing a non-invasive computational tool. This could reduce the need for repeated invasive procedures like cardiac catheterization, improve personalized disease management, and guide the development or selection of more effective, targeted therapeutic strategies for individual pediatric patients.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state limitations; however, the study was conducted on a small cohort of four pediatric PAH patients, which might limit the generalizability of the findings without further validation on larger cohorts.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The study suggests that computational modeling can be a promising tool for long-term monitoring of pediatric PAH. It also explicitly states its potential to inform and guide the development of future treatment strategies, indicating a direction towards using these models for personalized medicine and therapeutic optimization.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pediatric Cardiology</span>
                    
                    <span class="tag">Pulmonology</span>
                    
                    <span class="tag">Cardiovascular Medicine</span>
                    
                    <span class="tag">Medical Physics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Pulmonary Arterial Hypertension</span>
                    
                    <span class="tag tag-keyword">Pediatric</span>
                    
                    <span class="tag tag-keyword">Computational Modeling</span>
                    
                    <span class="tag tag-keyword">Hemodynamics</span>
                    
                    <span class="tag tag-keyword">Fluid-Structure Interaction</span>
                    
                    <span class="tag tag-keyword">Patient-Specific</span>
                    
                    <span class="tag tag-keyword">Disease Progression</span>
                    
                    <span class="tag tag-keyword">Non-invasive monitoring</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Pulmonary arterial hypertension (PAH) is a progressive cardiopulmonary disease that leads to increased pulmonary pressures, vascular remodeling, and eventual right ventricular (RV) failure. Pediatric PAH remains understudied due to limited data and the lack of targeted diagnostic and therapeutic strategies. In this study, we developed and calibrated multi-scale, patient-specific cardiovascular models for four pediatric PAH patients using longitudinal MRI and catheterization data collected approximately two years apart. Using the CRIMSON simulation framework, we coupled three-dimensional fluid-structure interaction (FSI) models of the pulmonary arteries with zero-dimensional (0D) lumped-parameter heart and Windkessel models to simulate patient hemodynamics. An automated Python-based optimizer was developed to calibrate boundary conditions by minimizing discrepancies between simulated and clinical metrics, reducing calibration time from weeks to days. Model-derived metrics such as arterial stiffness, pulse wave velocity, resistance, and compliance were found to align with clinical indicators of disease severity and progression. Our findings demonstrate that computational modeling can non-invasively capture patient-specific hemodynamic adaptation over time, offering a promising tool for monitoring pediatric PAH and informing future treatment strategies.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>